International Consensus on Risk Management of Diabetic Ketoacidosis in Patients with Type 1 Diabetes Treated with SGLT2 Inhibitors
21 May, 2019 | 20:19h | UTCCommentary: Recommendations issued for managing SGLT inhibitor-associated DKA risk in type 1 diabetes – Medwire News (free)